Ambry Genetics Corporation, a leading player in the genetic testing industry, is headquartered in the United States. Founded in 2004, the company has established itself as a pioneer in clinical genetic testing, focusing on hereditary cancer, cardiovascular conditions, and other genetic disorders. With a commitment to innovation, Ambry offers a comprehensive range of services, including next-generation sequencing and genetic counselling, which are distinguished by their accuracy and depth of analysis. Operating primarily in North America, Ambry Genetics has achieved significant milestones, including the launch of its proprietary testing platforms that enhance diagnostic capabilities. The company is recognised for its robust market position, having contributed to advancements in personalised medicine and genetic research. With a dedication to improving patient outcomes, Ambry Genetics continues to set the standard in the evolving landscape of genetic healthcare.
We don't have data for Ambry Genetics Corporation, but we can show you information about their parent organization instead.
View parent company